Skip to content
Preprint · CC-BY via OpenAlex

Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline

Claudia Schwarz, Slaven Stekovic, Miranka Wirth, Gloria S. Benson, Philipp Royer, Stephan J. Sigrist, Thomas Rudolf Pieber, Christopher Dammbrueck, Christoph Magnes, Tobias Eisenberg, Tobias Pendl, Jens Bohlken, Theresa Köbe, Frank Madeo, Agnes Flöel

Aging · 2018 · ▲ 165 citations

Abstract

Supplementation of spermidine, an autophagy(definition)-inducing agent, has been shown to protect against neurodegeneration and cognitive decline in aged animal models. The present translational study aimed to determine safety and tolerability of a wheat germ extract containing enhanced spermidine concentrations. In a preclinical toxicity study, supplementation of spermidine using this extract did not result in morbidities or changes in behavior in BALBc/Rj mice during the 28-days repeated-dose tolerance study. Post mortem examination of the mice organs showed no increase in tumorigenic and fibrotic events. In the human cohort (participants with subjective cognitive decline, n=30, 60 to 80 years of age), a 3-month randomized, placebo-controlled, double-blind Phase II trial was conducted with supplementation of the spermidine-rich plant extract (dosage: 1.2 mg/day). No differences were observed between spermidine and placebo-treated groups in vital signs, weight, clinical chemistry and hematological parameters of safety, as well as in self-reported health status at the end of intervention. Compliance rates above 85% indicated excellent tolerability. The data demonstrate that spermidine supplementation using a spermidine-rich plant extract is safe and well-tolerated in mice and older adults. These findings allow for longer-term intervention studies in humans to investigate the impact of spermidine treatment on cognition and brain integrity.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.18632/aging.101354
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Schwarz, C., Stekovic, S., Wirth, M., Benson, G.S., Royer, P., Sigrist, S.J., Pieber, T.R., Dammbrueck, C., Magnes, C., Eisenberg, T., Pendl, T., Bohlken, J., Köbe, T., Madeo, F., &amp; Flöel, A. (2018). Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline. <em>Aging</em>. https://doi.org/10.18632/aging.101354
Vancouver
Schwarz C, Stekovic S, Wirth M, Benson GS, Royer P, Sigrist SJ, et al. Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline. Aging. 2018. doi:10.18632/aging.101354.
BibTeX
@unpublished{claudia2018Safety, title = {Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline}, author = {Claudia Schwarz and Slaven Stekovic and Miranka Wirth and Gloria S. Benson and Philipp Royer and Stephan J. Sigrist and Thomas Rudolf Pieber and Christopher Dammbrueck and Christoph Magnes and Tobias Eisenberg and Tobias Pendl and Jens Bohlken and Theresa Köbe and Frank Madeo and Agnes Flöel}, journal = {Aging}, year = {2018}, doi = {10.18632/aging.101354}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings